As More COVID Therapeutics Are Approved, Supply Remains Limited in Chicago Area

This week, the Food and Drug Administration revoked Emergency Use Authorization for COVID-19 antibody drugs from Regeneron and Eli Lilly, a regulatory move that was expected because both drug makers have found that the infusion drugs are less able to target omicron due to the strain’s mutations. NBC 5’s Kate Chappell has more.